Diabetes was significantly delayed yet not abolished in anti-GITRL antibody-treated CD28−/− NOD mice and BDC2.5 T cells showed reduced migration and proliferation in the islets and pancreatic lymph nodes of anti-GITRL-treated recipient NOD mice as compared to untreated animals. This evidence concerns the gene CD28 and diabetes mellitus.